Nirsevimab Greatly Reduced Severe RSV in Infants
For infants in their first RSV season, the monoclonal antibody Nirsevimab (Beyfortus) was 80% effective against RSV-related ICU admission and...
infants
Combined effects of traffic-related air pollution, climate factors, and greenness on respiratory disease risk in infants
Goldizen, F. C., Sly, P. D. & Knibbs, L. D. Respiratory effects of air pollution on children. Pediatr. Pulmonol. 51,...
